Encision Inc. (ECIA)
OTCMKTS · Delayed Price · Currency is USD
0.3000
0.00 (0.00%)
Aug 11, 2025, 8:00 PM EDT
bluebird bio Market Cap
Encision has a market cap or net worth of $3.56 million as of August 14, 2025. Its market cap has decreased by -39.18% in one year.
Market Cap
3.56M
Enterprise Value
4.62M
Revenue
6.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
Market Cap Chart
Since August 13, 1996, Encision's market cap has decreased from 46.95M to 3.56M, a decrease of -92.41%. That is a compound annual growth rate of -8.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 3.56M | -33.31% |
| Dec 23, 2024 | 5.34M | 6.83% |
| Dec 29, 2023 | 5.00M | -14.97% |
| Dec 30, 2022 | 5.88M | -66.20% |
| Dec 31, 2021 | 17.40M | 249.40% |
| Dec 31, 2020 | 4.98M | 2.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |